Literature DB >> 16284610

Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD.

L E Weston1, A F Geczy, H Briscoe.   

Abstract

Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation. Pretransplant conditioning regimes cause release of proinflammatory cytokines that stimulate alloreactive donor T cells to attack recipient tissues. IL-10 has been shown to directly downregulate CD4+ T cells by suppressing IL-2 secretion and a critical role played by regulatory T cells has been demonstrated in animal models. One defining cytokine profile for regulatory T cells is the production of IL-10. Release of specific cytokines (IL-10, IL-4 and IFN-gamma) was detected using ELISPOT technology, following stimulation of donor peripheral blood mononuclear cells by recipient (human leukocyte antigen-matched sibling) alloantigen or by mitogen. Correlation between the frequency of cytokine-releasing cells and the development of acute GVHD was investigated. A high frequency of donor cells producing IL-10 in response to recipient alloantigen stimulation correlated with absence of acute GVHD after bone marrow transplant (BMT), while low frequency was strongly associated with severe GVHD. This study presents strong evidence that estimating the frequency of donor alloreactive cells producing IL-10 in response to recipient antigens will provide valuable information prior to BMT regarding potential transplant outcome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16284610     DOI: 10.1038/sj.bmt.1705218

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  7 in total

Review 1.  Making sense of regulatory T cell suppressive function.

Authors:  Itay Shalev; Moritz Schmelzle; Simon C Robson; Gary Levy
Journal:  Semin Immunol       Date:  2011-05-17       Impact factor: 11.130

2.  Immunization with host-type CD8{alpha}+ dendritic cells reduces experimental acute GVHD in an IL-10-dependent manner.

Authors:  Tomomi Toubai; Chelsea Malter; Isao Tawara; Chen Liu; Evelyn Nieves; Kathleen P Lowler; Yaping Sun; Pavan Reddy
Journal:  Blood       Date:  2009-11-18       Impact factor: 22.113

3.  Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia.

Authors:  Giorgia Serafini; Marco Andreani; Manuela Testi; MariaRosa Battarra; Andrea Bontadini; Eika Biral; Katharina Fleischhauer; Sarah Marktel; Guido Lucarelli; Maria Grazia Roncarolo; Rosa Bacchetta
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

4.  Increased Level of IFN-γ and IL-4 Spot-Forming Cells on ELISPOT Assay as Biomarkers for Acute Graft-Versus-Host Disease and Concurrent Infections.

Authors:  Masahiro Hirayama; Eiichi Azuma; Yoshihiro Komada
Journal:  Cells       Date:  2012-04-30       Impact factor: 6.600

5.  IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects.

Authors:  Y Liu; Y Wu; Y Wang; Y Cai; B Hu; G Bao; H Fang; L Zhao; S Ma; Q Cheng; Y Song; Y Liu; Z Zhu; H Chang; X Yu; A Sun; Y Zhang; D A A Vignali; D Wu; H Liu
Journal:  Leukemia       Date:  2014-11-03       Impact factor: 11.528

6.  Targeting Cytokines in GVHD Therapy.

Authors:  Sandeep Kumar; Hemn Mohammadpour; Xuefang Cao
Journal:  J Immunol Res Ther       Date:  2017-06-28

Review 7.  Seeking biomarkers for acute graft-versus-host disease: where we are and where we are heading?

Authors:  Xiao-Su Zhao; Xiao-Jun Huang
Journal:  Biomark Res       Date:  2019-08-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.